Short description
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases.
Description
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases. The company's current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity, a patented delivery vehicle.
Surface Ophthalmics was founded in 2017 and is based in Pleasanton, California.
Total funding
$$3123123
Sign in for full access
Location
Pleasanton, California, United States, North America
Founded on
January 1, 2016
Non-profit?
No
Acquired?
No
Employees count
1-10
Founders
Kamran Hosseini, Mark Baum